Amneal Submits Modest Guidance Raise Following Strong Second Quarter

Firm Now Expects To Make An Additional $50m This Year

Blue arrow pointing up representing progress
• Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Earnings

More from Business